Skip to main content

Advertisement

SpringerLink
Log in

Genetic variation in the TP63 gene is associated with lung cancer risk in the Han population

  • Research Article
  • Published:
Tumor Biology

Abstract

Lung cancer is one of the most common malignant tumors that seriously threaten human health. Current evidence suggests that heredity contributes to the progression of lung cancer. To investigate and validate potential genetic associations with the risk of lung cancer, we conducted a case–control study including 309 cases and 310 controls from Xi’an City, which is located in northwest China, and genotyped six SNPs in five genes, which are related to metabolic process. Overall, our results show that the SNP rs10937405 was associated with a decreased occurrence of lung cancer (OR = 0.72; 95 % CI = 0.56–0.92; p = 0.009). In the genetic models analysis, we found that genotype “CT” of rs10937405 in TP63 was associated with a decreased lung cancer risk (OR = 0.71; 95 % CI, 0.51–0.99; p = 0.031); the genotype “TT” of rs10937405 showed a decreased lung cancer risk in the co-dominant model (OR = 0.53; 95 % CI, 0.30–0.95; p = 0.031). The genotype “CT-TT” of rs10937405 also showed a decreased lung cancer risk in the dominant model (OR = 0.67; 95 % CI, 0.49–0.92; p = 0.014) and the log-additive model (OR = 0.72; 95 % CI, 0.56–0.92; p = 0.0085). The genotype “CC-CT” of rs10937405 confers a higher risk of lung cancer for males than females. Our results, combined with those from previous studies, suggest that genetic variation in TP63 may influence lung cancer susceptibility in the Han population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  2. Chen WQ, Zhang SW, Zou XN, Zhao P. Cancer incidence and mortality in China, 2006. Chin J Cancer Res. 2011;23:3–9.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  3. Chen WQ, Zhang SW, Zou XN. Evaluation on the incidence, mortality and tendency of lung cancer in China. Thorac Cancer. 2010;1:35–40.

    Article  Google Scholar 

  4. Shields PG. Molecular epidemiology of smoking and lung cancer. Oncogene. 2002;21:6870–6.

    Article  PubMed  CAS  Google Scholar 

  5. Wang Y, Broderick P, Matakidou A, Vijayakrishnan J, Eisen T, Houlston RS. Variation in TP63 is associated with lung adenocarcinoma in the UK population. Cancer Epidemiol Biomarkers Prev. 2011;20:1453–62.

    Article  PubMed  CAS  Google Scholar 

  6. Hu Z, Wu C, Shi Y, Guo H, Zhao X, Yin Z, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet. 2011;43:792–6.

    Article  PubMed  CAS  Google Scholar 

  7. Rafnar T, Sulem P, Besenbacher S, Gudbjartsson DF, Zanon C, Gudmundsson J, et al. Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer risk. Cancer Res. 2011;71:1356–61.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet. 2009; UNIT 2.12. doi:10.1002/0471142905.

  9. Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347–51.

    Article  PubMed  CAS  Google Scholar 

  10. Adamec C. Example of the use of the nonparametric test. Test χ 2 for comparison of 2 independent examples. Cesk Zdrav. 1964;12:613–9.

    PubMed  CAS  Google Scholar 

  11. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22:1928–9.

    Article  PubMed  CAS  Google Scholar 

  12. Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ. 2000;320:1468.

    CAS  Google Scholar 

  13. Flores ER. The roles of p63 in cancer. Cell Cycle. 2007;6:300–4.

    Article  PubMed  CAS  Google Scholar 

  14. Hernandez-Boussard T, Rodriguez-Tome P, Montesano R, Hainaut P. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer. Hum Mutat. 1999;14:1–8.

    CAS  Google Scholar 

  15. Melino G. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ. 2011;18:1487–99.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  16. Massion PP, Zou Y, Uner H, Kiatsimkul P, Wolf HJ, Baron AE, et al. Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer. PLoS ONE. 2009;4:e5611.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Miki D, Kubo M, Takahashi A, Yoon KA, Kim J, Lee GK, et al. Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet. 2010;42:893–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work is supported by the National Natural Science Foundation 31260252 and Major Training Program of Tibet University for Nationalities (no.12KJZRYMY10). We are grateful to all the patients and individuals in the study who made this work possible. We would also like to thank the clinicians and hospital staff who contributed to data collection for this study.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Key Laboratory of High Altitude Environment and Genes Related to Diseases of Tibet Autonomous Region, School of Medicine, Tibet University for Nationalities, Xianyang, Shaanxi, 712082, China

    Qun-Ying Hu, Tian-Bo Jin, Li Wang & Long-Li Kang

  2. Affiliated Hospital of Tibet University for Nationalities, Xianyang, Shaanxi, 712082, China

    Qun-Ying Hu & Guinian Liang

  3. School of Life Sciences, Northwest University, Xi’an, Shaanxi, 710069, China

    Tian-Bo Jin & Le Zhang

  4. National Engineering Research Center for Miniaturized Detection Systems, Xi’an, Shaanxi, 710069, China

    Tian-Bo Jin & Tingting Geng

  5. #6 East Wenhui Road, Xianyang, Shaanxi, 712082, China

    Long-Li Kang

Authors
  1. Qun-Ying Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tian-Bo Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Li Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Le Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tingting Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guinian Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Long-Li Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Long-Li Kang.

Additional information

Qun-Ying Hu and Tian-Bo Jin contributed equally to this work

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, QY., Jin, TB., Wang, L. et al. Genetic variation in the TP63 gene is associated with lung cancer risk in the Han population. Tumor Biol. 35, 1863–1866 (2014). https://doi.org/10.1007/s13277-013-1248-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1248-3

Keywords

Search

Navigation